rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Douglas Carr

SVP Finance & Operations

Company insider

Files Form 4 as: SVP Finance & Operations, Century Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
48
Buys
0
Sells
22
Bought
$0
Sold
$68K
Companies
1
Companies where not an officer
0
First trade
25 Jan 2022
Last trade
14 Sep 2026
Last filed
15 Sep 2026

Companies traded

Where they are an officer
IPSC Century TherapeuticsOfficer · Biotechnology · last 14 Sep 20260 buys · 22 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Sep 2026filed 15 Sep 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$3,2001,658 at $1.93filing
14 Sep 2026filed 15 Sep 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$3,2001,658 at $1.93filing
8 Sep 2026filed 9 Sep 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$521254 at $2.05filing
8 Sep 2026filed 9 Sep 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$521254 at $2.05filing
3 Aug 2026filed 5 Aug 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$544275 at $1.98filing
3 Aug 2026filed 5 Aug 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$545275 at $1.98filing
12 Jun 2026filed 15 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$3,6921,654 at $2.23filing
12 Jun 2026filed 15 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$3,6881,654 at $2.23filing
8 Jun 2026filed 9 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$526249 at $2.11filing
8 Jun 2026filed 9 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$525249 at $2.11filing
4 May 2026filed 6 May 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$618264 at $2.34filing
4 May 2026filed 6 May 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$618264 at $2.34filing
12 Mar 2026filed 16 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$18K7,043 at $2.55filing
12 Mar 2026filed 16 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$18K7,043 at $2.55filing
9 Mar 2026filed 11 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$626247 at $2.54filing
9 Mar 2026filed 11 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$627247 at $2.54filing
3 Feb 2026filed 5 Feb 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$589323 at $1.82filing
3 Feb 2026filed 5 Feb 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$588323 at $1.82filing
2 Feb 2026filed 4 Feb 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code A—110,000 at $0.00filing
2 Feb 2026filed 4 Feb 2026IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—225,000 at $0.00filing

Sectors

Health Care22

Buys in green, sells in red, by the company’s sector.

Related people

Gregory RussottiOfficer · Officer at Century Therapeutics, filing Form 4 there in the last year
Brent PfeiffenbergerPresident and CEO · President and CEO at Century Therapeutics, filing Form 4 there in the last year
Joseph TruittDirector · Director at Century Therapeutics, filing Form 4 there in the last year
Chad CowanChief Scientific Officer · Chief Scientific Officer at Century Therapeutics, filing Form 4 there in the last year
Alessandro RivaDirector · Director at Century Therapeutics, filing Form 4 there in the last year